GNL37: UK experimental use exemptions

The exemptions to patent infringement applicable in the UK to life sciences products are often a source of confusion. This is not least because of the introduction of a third such exemption on 1 October 2014. The extent of protection offered by each differs, but to some extent overlaps, and there is only slim guidance from the courts. This article attempts to disentangle the issues raised by these exemptions, by explaining what they are, and what we know about their field of application and scope.

This content is restricted to members. To view this content please register or login below to view this content.

Sign-Up For Free

Sign-up to receive up-to-date information and advice on tax developments within your industry.

Sign-up for free